(Q37682873)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20108987%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

review article

1 reference

title

Optimizing the use of tumour necrosis factor inhibitors in Crohn's disease: a practical approach (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20108987%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

0 references

0 references

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20108987%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

author name string

Maria Josefina Etchevers

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20108987%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

Elena Ricart

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20108987%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

publication date

1 January 2010

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20108987%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20108987%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

volume

70

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20108987%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20108987%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

page(s)

109-120

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20108987%20AND%20SRC:MED&resulttype=core&format=json

Adalimumab induction therapy for Crohn disease previously treated with infliximab: a randomized trial

17 January 2020

cites work

1 reference

Crossref

https://api.crossref.org/works/10.2165%2F11533700-000000000-00000

Clinical, biological, and endoscopic picture of attacks of Crohn's disease. Evolution on prednisolone. Groupe d'Etude Thérapeutique des Affections Inflammatoires Digestives.

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.2165%2F11533700-000000000-00000

Crohn's disease: a review of current treatment with a focus on biologics.

21 January 2018

1 reference

12 December 2020

Maintenance infliximab for Crohn's disease: the ACCENT I randomised trial

1 reference

12 December 2020

Intravenous hydrocortisone premedication reduces antibodies to infliximab in Crohn's disease: a randomized controlled trial

1 reference

12 December 2020

Comparison of two adalimumab treatment schedule strategies for moderate-to-severe Crohn's disease: results from the CHARM trial

1 reference

12 December 2020

Inflammatory Bowel Disease

1 reference

12 December 2020

Infliximab dose intensification in Crohn's disease

1 reference

12 December 2020

Early combined immunosuppression or conventional management in patients with newly diagnosed Crohn's disease: an open randomised trial.

1 reference

12 December 2020

Development and validation of an endoscopic index of the severity for Crohn's disease: a prospective multicentre study. Groupe d'Etudes Thérapeutiques des Affections Inflammatoires du Tube Digestif (GETAID)

1 reference

12 December 2020

European evidence based consensus on the diagnosis and management of Crohn's disease: current management.

1 reference

12 December 2020

Influence of Immunogenicity on the Long-Term Efficacy of Infliximab in Crohn's Disease

1 reference

12 December 2020

Infliximab reintroduction is not associated to a higher rate of immune-related adverse effects in patients with inflammatory bowel disease initially treated with a three-infusion induction regimen.

1 reference

12 December 2020

Mucosal healing predicts long-term outcome of maintenance therapy with infliximab in Crohn's disease.

1 reference

12 December 2020

Human anti-tumor necrosis factor monoclonal antibody (adalimumab) in Crohn's disease: the CLASSIC-I trial

1 reference

12 December 2020

Prevalence and Factors Related to Hepatitis B and C in Inflammatory Bowel Disease Patients in Spain: A Nationwide, Multicenter Study

1 reference

12 December 2020

Effectiveness of concomitant immunosuppressive therapy in suppressing the formation of antibodies to infliximab in Crohn's disease

1 reference

12 December 2020

American gastroenterological association consensus development conference on the use of biologics in the treatment of inflammatory bowel disease, June 21-23, 2006.

1 reference

12 December 2020

Adalimumab for maintenance of clinical response and remission in patients with Crohn's disease: the CHARM trial

1 reference

12 December 2020

Long term outcome of patients with active Crohn's disease exhibiting extensive and deep ulcerations at colonoscopy

1 reference

12 December 2020

Endoscopic and histological healing with infliximab anti-tumor necrosis factor antibodies in Crohn's disease: A European multicenter trial

1 reference

12 December 2020

Long-term outcome of Crohn's disease following corticosteroid-induced remission

1 reference

12 December 2020

Adalimumab for maintenance treatment of Crohn's disease: results of the CLASSIC II trial.

1 reference

12 December 2020

A short-term study of chimeric monoclonal antibody cA2 to tumor necrosis factor alpha for Crohn's disease. Crohn's Disease cA2 Study Group.

1 reference

12 December 2020

Scheduled maintenance treatment with infliximab is superior to episodic treatment for the healing of mucosal ulceration associated with Crohn's disease

1 reference

12 December 2020

Comparison of scheduled and episodic treatment strategies of infliximab in Crohn's disease

1 reference

12 December 2020

Adalimumab for Crohn's disease with intolerance or lost response to infliximab: a 3-year single-centre experience

1 reference

12 December 2020

Endoscopic and histologic healing of Crohn's (ileo-) colitis with azathioprine

1 reference

12 December 2020

Healing of severe recurrent ileitis with azathioprine therapy in patients with Crohn's disease

1 reference

12 December 2020

Infliximab maintenance treatment reduces hospitalizations, surgeries, and procedures in fistulizing Crohn's disease

1 reference

12 December 2020

Predictors of severe Crohn's disease

1 reference

12 December 2020

Impact of the increasing use of immunosuppressants in Crohn's disease on the need for intestinal surgery

1 reference

12 December 2020

Loss of response and requirement of infliximab dose intensification in Crohn's disease: a review.

1 reference

12 December 2020

Efficacy and safety of retreatment with anti-tumor necrosis factor antibody (infliximab) to maintain remission in Crohn's disease.

1 reference

12 December 2020

Association of trough serum infliximab to clinical outcome after scheduled maintenance treatment for Crohn's disease

1 reference

12 December 2020

Long-term outcome of treatment with infliximab in 614 patients with Crohn's disease: results from a single-centre cohort.

1 reference

12 December 2020

Tumor necrosis factor-alpha antibody for maintenance of remission in Crohn's disease

1 reference

12 December 2020

Infliximab prevents Crohn's disease recurrence after ileal resection

1 reference

12 December 2020

Hepatosplenic T-cell lymphoma in a patient with Crohn's disease

1 reference

12 December 2020

American Gastroenterological Association Institute medical position statement on corticosteroids, immunomodulators, and infliximab in inflammatory bowel disease

1 reference

12 December 2020

Treatment of Crohn's disease with 6-mercaptopurine. A long-term, randomized, double-blind study

1 reference

12 December 2020

Certolizumab pegol for the treatment of Crohn's disease

1 reference

12 December 2020

Predictors of Crohn's disease

1 reference

12 December 2020

Mucosal healing in inflammatory bowel disease: results from a Norwegian population-based cohort

1 reference

12 December 2020

Maintenance therapy with certolizumab pegol for Crohn's disease

1 reference

12 December 2020

Enhanced secretion of tumour necrosis factor-alpha, IL-6, and IL-1 beta by isolated lamina propria mononuclear cells from patients with ulcerative colitis and Crohn's disease

1 reference

12 December 2020

Infliximab for the treatment of fistulas in patients with Crohn's disease

1 reference

12 December 2020

Withdrawal of immunosuppression in Crohn's disease treated with scheduled infliximab maintenance: a randomized trial

1 reference

12 December 2020

A multicenter trial of 6-mercaptopurine and prednisone in children with newly diagnosed Crohn's disease

1 reference

12 December 2020

Glucocorticoid treatment in ileal Crohn's disease: relief of symptoms but not of endoscopically viewed inflammation

1 reference

12 December 2020

A randomized, double-blind, controlled withdrawal trial in Crohn's disease patients in long-term remission on azathioprine

1 reference

12 December 2020

Incidence and importance of antibody responses to infliximab after maintenance or episodic treatment in Crohn's disease

1 reference

12 December 2020

Infliximab plus azathioprine for steroid-dependent Crohn's disease patients: a randomized placebo-controlled trial

1 reference

12 December 2020

Risk factors for opportunistic infections in patients with inflammatory bowel disease.

1 reference

12 December 2020

Effects of adalimumab therapy on incidence of hospitalization and surgery in Crohn's disease: results from the CHARM study

1 reference

12 December 2020

Tumour necrosis factor and Crohn's disease

1 reference

12 December 2020

Infliximab maintenance therapy for fistulizing Crohn's disease

1 reference

12 December 2020

Influence of Trough Serum Levels and Immunogenicity on Long-term Outcome of Adalimumab Therapy in Crohn's Disease

1 reference

12 December 2020